Get the app!
Back to Trades

Gilmer Daniel B.

DirectorCIK 0002122703

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Gilmer Daniel B., Director, has filed 2 SEC reports (2026), all concentrated in Armata Pharmaceuticals, Inc. (ARMP), totaling $662.5K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Apr 28ARMP
Armata Pharmaceuticals, Inc.
Gilmer Daniel B.DirectorAward$662.5K
Apr 28ARMP
Armata Pharmaceuticals, Inc.
Gilmer Daniel B.DirectorOther$0

2 filings